bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

4427 Articles (3576 medRxiv, 851 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe Infection
Chaudhry, F., Bulka, H., Rathnam, A. S., Said, O. M., Lin, J., Lorigan, H., Bernitsas, E., Rube, J., Korzeniewski, S. J., Memon, A. B., Levy, P. D., Javed, A., Lisak, R., Cerghet, M.
10.1101/2020.05.27.20114827 — Posted: 2020-05-29
Study protocol for COvid-19 Vascular sERvice (COVER) study: The impact of the COVID-19 pandemic on the provision, practice and outcomes of vascular surgery
Vascular and Endovascular Research Network, , Benson, R. A., Bosanquet, D. C., Nandhra, S., Shalhoub, J., Saratzis, A., Forsythe, R., Onida, S., Dovell, G., Hitchman, L., Dattani, N., Preece, R., Ambler, G. K., Imray, C.
10.1101/2020.05.27.20114322 — Posted: 2020-05-29
Determinants of intent to uptake Coronavirus vaccination among respondents in Saudi Arabia: a web-based national survey
Padhi, B. K., A. Almohaithef, M.
10.1101/2020.05.27.20114413 — Posted: 2020-05-29
Knowledge, attitude, and perceptions towards the 2019 Coronavirus Pandemic: A bi-national survey in Africa
Elnadi, H., Odetokun, I. A., Bolarinwa, O., Ahmed, Z., Okechukwu, O., Al-Mustapha, A. I.
10.1101/2020.05.27.20113951 — Posted: 2020-05-29
Lopinavir-Ritonavir in treatment of COVID-19: A dynamic systematic benefit-risk assessment
Osborne, V., Davies, M., Lane, S., Evans, A., Denyer, J., Dhanda, S., Roy, D., Shakir, S. A.
10.1101/2020.05.27.20114470 — Posted: 2020-05-29
Belief in Conspiracy Theory about COVID-19 Predicts Mental Health and Well-being -- A Study of Healthcare Staff in Ecuador
Chen, X., Zhang, S. X., Jahanshahi, A. A., Alvarez-Risco, A., Dai, H., Li, J., Ibarra, V. G.
10.1101/2020.05.26.20113258 — Posted: 2020-05-29
Lessons from movement ecology for the return to work: modeling contacts and the spread of COVID-19
Shaw, A. K., White, L. A., Michalska-Smith, M., Borer, E. T., Craft, M. E., Seabloom, E. W., Snell-Rood, E., Travisano, M.
10.1101/2020.05.27.20114728 — Posted: 2020-05-29
Distinctive trajectories of COVID-19 epidemic by age and gender: a retrospective modeling of the epidemic in South Korea
Yu, X., Duan, J., Jiang, Y., Zhang, H.
10.1101/2020.05.27.20114819 — Posted: 2020-05-29
Identifying the measurements required to estimate rates of COVID-19 transmission, infection, and detection, using variational data assimilation
Armstrong, E., Gerardin, J., Runge, M.
10.1101/2020.05.27.20112987 — Posted: 2020-05-29
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Rosenberg, E. S., Tesoriero, J. M., Rosenthal, E. M., Chung, R., Barranco, M. A., Styer, L. M., Parker, M. M., Leung, S.-Y. J., Morne, J., Greene, D., Holtgrave, D. R., Hoefer, D., Kumar, J., Udo, T., Hutton, B., Zucker, H. A.
10.1101/2020.05.25.20113050 — Posted: 2020-05-29

RSS  Collection RSS | JSON

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).